Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 143
- Locations
- 2
- Primary Endpoint
- physician/lab-derived instruments of clinical efficacy as measured by DAS28 change and DAS28 remission.
Study Overview
Brief Summary
The overall goal of this proposal is to address barriers to the use of patient reported outcome (PRO) data in the Dept. of Veterans Affairs (VA) health care system.
Detailed Description
This is a randomized, controlled, single-blinded study that compares outcome data in patients for whom PRO data either is or is not made available to the treating physician. The question addressed by this proposal is whether patient reported outcome (PRO) data change patient's outcomes. The hypothesis is that the availability of these data in the form of the patient-completed Multidimensional Health Assessment Questionnaire/routine assessment of patient index data (MDHAQ/RAPID3) questionnaire will change patient-centric outcomes such as patient reported well-being, patient satisfaction and medication compliance.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •US veteran
- •Within North Florida/South Georgia (NF/SG) Veterans Integrated Service Network
Exclusion Criteria
- •Outside of service network
- •Non-veteran
Outcomes
Primary Outcomes
physician/lab-derived instruments of clinical efficacy as measured by DAS28 change and DAS28 remission.
Time Frame: 1 year
Physician/lab-derived instruments of clinical efficacy as measured by DAS28 change and DAS28 remission.
Secondary Outcomes
- patient satisfaction(1 year)
- medication compliance(1 year)